Join
Live feed
·
INSIDERFilingvia Quantisnow
Monopar Therapeutics Inc. logo

Tsuchimoto Kim R converted options into 9,956 shares and covered exercise/tax liability with 4,082 shares, increasing direct ownership by 13% to 50,470 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNPR (Monopar Therapeutics Inc.) and more on Quantisnow.